- Enovis to Host First Quarter 2024 Results Conference Call on May 2nd
- Enovis to Participate in the 23rd Annual Needham Virtual Healthcare Conference
- Enovis Announces Fourth Quarter and Full Year 2023 Results
- Enovis™ to Highlight Latest Technologies Across the Orthopedic Care Continuum at 2024 AAOS Annual Meeting
- Enovis to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024
- Enovis Showcases New Foot & Ankle Offerings at the ACFAS Annual Meeting
- Enovis to Host Fourth Quarter and Full Year 2023 Conference Call on February 22nd
- Enovis Introduces the DonJoy ROAM™ OA Knee Brace
- Enovis finalise l’acquisition de LimaCorporate S.p.A.
- エノビス (Enovis) がリマ・コーポレート (LimaCorporate S.p.A) の買収を完了
More ▼
Key statistics
On Friday, Enovis Corp (0I1B:LSE) closed at 55.66, -14.83% below its 52-week high of 65.36, set on Jul 20, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | 55.66 |
Average volume | 43.40 |
---|---|
Shares outstanding | 54.84m |
Free float | 51.70m |
P/E (TTM) | -- |
Market cap | 3.04bn USD |
EPS (TTM) | -0.9987 USD |
Data delayed at least 20 minutes, as of Apr 19 2024 18:23 BST.
More ▼